Home › Companies › CELLDEX THERAPEUTICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and CELLDEX THERAPEUTICS INC.’s Form 8-K, filed June 14, 2024 (Item 5.07 on EDGAR). Page generated November 1, 2026.
Meeting of June 13, 2024: 12 items on CELLDEX THERAPEUTICS INC.’s Form 8-K, filed June 14, 2024: 9 elected · 3 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore CELLDEX THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are CELLDEX THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 14, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Karen L. Shoos (Chair of the Board) | 54,662,615 | 791,355 | 113,213 | -- | 2,522,112 | 99% | Elected | — |
| Elect Director: Anthony S. Marucci (Chief Executive Officer) | 54,704,706 | 749,690 | 112,787 | -- | 2,522,112 | 99% | Elected | — |
| Elect Director: Keith L. Brownlie | 54,774,708 | 679,666 | 112,809 | -- | 2,522,112 | 99% | Elected | — |
| Elect Director: Cheryl L. Cohen | 54,830,898 | 622,096 | 114,189 | -- | 2,522,112 | 99% | Elected | — |
| Elect Director: Herbert J. Conrad | 53,985,260 | 1,469,124 | 112,799 | -- | 2,522,112 | 97% | Elected | — |
| Elect Director: Rita I. Jain, M.D. | 54,826,340 | 627,680 | 113,163 | -- | 2,522,112 | 99% | Elected | — |
| Elect Director: James J. Marino | 54,670,676 | 783,775 | 112,732 | -- | 2,522,112 | 99% | Elected | — |
| Elect Director: Garry A. Neil, M.D. | 54,807,327 | 645,682 | 114,174 | -- | 2,522,112 | 99% | Elected | — |
| Elect Director: Harry H. Penner, Jr. | 54,658,404 | 795,521 | 113,258 | -- | 2,522,112 | 99% | Elected | — |
| 2. The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024 | 57,840,728 | 122,376 | 126,191 | -- | -- | 99.7% | Approved | — |
| 3. An amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of the shares reserved for issuance thereunder by 3,200,000 shares to 7,500,000 shares | 53,889,397 | 1,561,316 | 116,470 | -- | 2,522,112 | 97% | Approved | — |
| Proposal 4: The stockholders voted to approve, on an advisory, non-binding basis, the compensation for the Company's named executive officers as disclosed in the Proxy Statement. | 54,182,916 | 945,004 | 439,263 | -- | 2,522,112 | 98% | Approved | — |
Source: CELLDEX THERAPEUTICS INC., Form 8-K, filed with the SEC on June 14, 2024 — read the filing on EDGAR.
Each item below shows how the 202 asset managers that disclosed a CELLDEX THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Anthony S. Marucci
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Anthony S. Marucci (Chief Executive Officer)”): 54,704,706 for, 749,690 against, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2025.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 62 asset managers below reported 29,676,409 for, 221 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,368,618 | 0 | 0 | 0 | For |
| Vanguard | 8,068,532 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,161,201 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,485,625 | 0 | 0 | 0 | For |
| BlackRock | 1,550,187 | 0 | 0 | 0 | For |
| State Street | 1,502,238 | 221 | 0 | 0 | For |
| Hartford | 582,176 | 0 | 0 | 0 | For |
| Charles Schwab | 502,440 | 0 | 0 | 0 | For |
| TIAA | 369,232 | 0 | 0 | 0 | For |
| Prudential/PGIM | 341,172 | 0 | 0 | 0 | For |
| Equitable | 172,663 | 0 | 0 | 0 | For |
| American Century | 155,788 | 0 | 0 | 0 | For |
| John Hancock | 134,953 | 0 | 0 | 0 | For |
| Northwestern Mutual | 99,267 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 87,220 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,047 | 0 | 0 | 0 | For |
| First Trust | 78,073 | 0 | 0 | 0 | For |
| Brighthouse | 71,470 | 0 | 0 | 0 | For |
| Invesco | 70,952 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 67,207 | 0 | 0 | 0 | For |
| Principal | 51,902 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,600 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 49,440 | 0 | 0 | 0 | For |
| Goldman Sachs | 45,216 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 45,088 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Cheryl L. Cohen
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Cheryl L. Cohen”): 54,830,898 for, 622,096 against, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2025.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 62 asset managers below reported 29,676,468 for, 162 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,368,618 | 0 | 0 | 0 | For |
| Vanguard | 8,068,532 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,161,201 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,485,625 | 0 | 0 | 0 | For |
| BlackRock | 1,550,187 | 0 | 0 | 0 | For |
| State Street | 1,502,297 | 162 | 0 | 0 | For |
| Hartford | 582,176 | 0 | 0 | 0 | For |
| Charles Schwab | 502,440 | 0 | 0 | 0 | For |
| TIAA | 369,232 | 0 | 0 | 0 | For |
| Prudential/PGIM | 341,172 | 0 | 0 | 0 | For |
| Equitable | 172,663 | 0 | 0 | 0 | For |
| American Century | 155,788 | 0 | 0 | 0 | For |
| John Hancock | 134,953 | 0 | 0 | 0 | For |
| Northwestern Mutual | 99,267 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 87,220 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,047 | 0 | 0 | 0 | For |
| First Trust | 78,073 | 0 | 0 | 0 | For |
| Brighthouse | 71,470 | 0 | 0 | 0 | For |
| Invesco | 70,952 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 67,207 | 0 | 0 | 0 | For |
| Principal | 51,902 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,600 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 49,440 | 0 | 0 | 0 | For |
| Goldman Sachs | 45,216 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 45,088 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Garry Neil, M.D.
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Garry A. Neil, M.D.”): 54,807,327 for, 645,682 against, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2025.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 62 asset managers below reported 29,669,735 for, 6,895 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,368,618 | 0 | 0 | 0 | For |
| Vanguard | 8,068,532 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,161,201 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,485,625 | 0 | 0 | 0 | For |
| BlackRock | 1,550,187 | 0 | 0 | 0 | For |
| State Street | 1,502,105 | 354 | 0 | 0 | For |
| Hartford | 582,176 | 0 | 0 | 0 | For |
| Charles Schwab | 502,440 | 0 | 0 | 0 | For |
| TIAA | 369,232 | 0 | 0 | 0 | For |
| Prudential/PGIM | 341,172 | 0 | 0 | 0 | For |
| Equitable | 172,663 | 0 | 0 | 0 | For |
| American Century | 155,788 | 0 | 0 | 0 | For |
| John Hancock | 134,953 | 0 | 0 | 0 | For |
| Northwestern Mutual | 99,267 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 87,220 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,047 | 0 | 0 | 0 | For |
| First Trust | 78,073 | 0 | 0 | 0 | For |
| Brighthouse | 71,470 | 0 | 0 | 0 | For |
| Invesco | 70,952 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 67,207 | 0 | 0 | 0 | For |
| Principal | 51,902 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,600 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 49,440 | 0 | 0 | 0 | For |
| Goldman Sachs | 45,216 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 45,088 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Harry H. Penner, Jr.
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Harry H. Penner, Jr.”): 54,658,404 for, 795,521 against, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2025.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 62 asset managers below reported 29,668,407 for, 8,223 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,368,618 | 0 | 0 | 0 | For |
| Vanguard | 8,068,532 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,161,201 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,485,625 | 0 | 0 | 0 | For |
| BlackRock | 1,550,187 | 0 | 0 | 0 | For |
| State Street | 1,502,046 | 413 | 0 | 0 | For |
| Hartford | 582,176 | 0 | 0 | 0 | For |
| Charles Schwab | 502,440 | 0 | 0 | 0 | For |
| TIAA | 369,232 | 0 | 0 | 0 | For |
| Prudential/PGIM | 341,172 | 0 | 0 | 0 | For |
| Equitable | 172,663 | 0 | 0 | 0 | For |
| American Century | 155,788 | 0 | 0 | 0 | For |
| John Hancock | 134,953 | 0 | 0 | 0 | For |
| Northwestern Mutual | 99,267 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 87,220 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,047 | 0 | 0 | 0 | For |
| First Trust | 78,073 | 0 | 0 | 0 | For |
| Brighthouse | 71,470 | 0 | 0 | 0 | For |
| Invesco | 70,952 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 67,207 | 0 | 0 | 0 | For |
| Principal | 51,902 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,600 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 49,440 | 0 | 0 | 0 | For |
| Goldman Sachs | 45,216 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 45,088 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Herbert J. Conrad
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Herbert J. Conrad”): 53,985,260 for, 1,469,124 against, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2025.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 62 asset managers below reported 29,661,674 for, 14,956 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,368,618 | 0 | 0 | 0 | For |
| Vanguard | 8,068,532 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,161,201 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,485,625 | 0 | 0 | 0 | For |
| BlackRock | 1,550,187 | 0 | 0 | 0 | For |
| State Street | 1,501,854 | 605 | 0 | 0 | For |
| Hartford | 582,176 | 0 | 0 | 0 | For |
| Charles Schwab | 502,440 | 0 | 0 | 0 | For |
| TIAA | 369,232 | 0 | 0 | 0 | For |
| Prudential/PGIM | 341,172 | 0 | 0 | 0 | For |
| Equitable | 172,663 | 0 | 0 | 0 | For |
| American Century | 155,788 | 0 | 0 | 0 | For |
| John Hancock | 134,953 | 0 | 0 | 0 | For |
| Northwestern Mutual | 99,267 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 87,220 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,047 | 0 | 0 | 0 | For |
| First Trust | 78,073 | 0 | 0 | 0 | For |
| Brighthouse | 71,470 | 0 | 0 | 0 | For |
| Invesco | 70,952 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 67,207 | 0 | 0 | 0 | For |
| Principal | 51,902 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,600 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 49,440 | 0 | 0 | 0 | For |
| Goldman Sachs | 45,216 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 45,088 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: James J. Marino
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: James J. Marino”): 54,670,676 for, 783,775 against, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2025.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 62 asset managers below reported 29,676,468 for, 162 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,368,618 | 0 | 0 | 0 | For |
| Vanguard | 8,068,532 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,161,201 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,485,625 | 0 | 0 | 0 | For |
| BlackRock | 1,550,187 | 0 | 0 | 0 | For |
| State Street | 1,502,297 | 162 | 0 | 0 | For |
| Hartford | 582,176 | 0 | 0 | 0 | For |
| Charles Schwab | 502,440 | 0 | 0 | 0 | For |
| TIAA | 369,232 | 0 | 0 | 0 | For |
| Prudential/PGIM | 341,172 | 0 | 0 | 0 | For |
| Equitable | 172,663 | 0 | 0 | 0 | For |
| American Century | 155,788 | 0 | 0 | 0 | For |
| John Hancock | 134,953 | 0 | 0 | 0 | For |
| Northwestern Mutual | 99,267 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 87,220 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,047 | 0 | 0 | 0 | For |
| First Trust | 78,073 | 0 | 0 | 0 | For |
| Brighthouse | 71,470 | 0 | 0 | 0 | For |
| Invesco | 70,952 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 67,207 | 0 | 0 | 0 | For |
| Principal | 51,902 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,600 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 49,440 | 0 | 0 | 0 | For |
| Goldman Sachs | 45,216 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 45,088 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Karen L. Shoos
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Karen L. Shoos (Chair of the Board)”): 54,662,615 for, 791,355 against, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2025.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 62 asset managers below reported 29,676,409 for, 221 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,368,618 | 0 | 0 | 0 | For |
| Vanguard | 8,068,532 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,161,201 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,485,625 | 0 | 0 | 0 | For |
| BlackRock | 1,550,187 | 0 | 0 | 0 | For |
| State Street | 1,502,238 | 221 | 0 | 0 | For |
| Hartford | 582,176 | 0 | 0 | 0 | For |
| Charles Schwab | 502,440 | 0 | 0 | 0 | For |
| TIAA | 369,232 | 0 | 0 | 0 | For |
| Prudential/PGIM | 341,172 | 0 | 0 | 0 | For |
| Equitable | 172,663 | 0 | 0 | 0 | For |
| American Century | 155,788 | 0 | 0 | 0 | For |
| John Hancock | 134,953 | 0 | 0 | 0 | For |
| Northwestern Mutual | 99,267 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 87,220 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,047 | 0 | 0 | 0 | For |
| First Trust | 78,073 | 0 | 0 | 0 | For |
| Brighthouse | 71,470 | 0 | 0 | 0 | For |
| Invesco | 70,952 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 67,207 | 0 | 0 | 0 | For |
| Principal | 51,902 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,600 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 49,440 | 0 | 0 | 0 | For |
| Goldman Sachs | 45,216 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 45,088 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Keith L. Brownlie
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Keith L. Brownlie”): 54,774,708 for, 679,666 against, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2025.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 62 asset managers below reported 29,676,468 for, 162 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,368,618 | 0 | 0 | 0 | For |
| Vanguard | 8,068,532 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,161,201 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,485,625 | 0 | 0 | 0 | For |
| BlackRock | 1,550,187 | 0 | 0 | 0 | For |
| State Street | 1,502,297 | 162 | 0 | 0 | For |
| Hartford | 582,176 | 0 | 0 | 0 | For |
| Charles Schwab | 502,440 | 0 | 0 | 0 | For |
| TIAA | 369,232 | 0 | 0 | 0 | For |
| Prudential/PGIM | 341,172 | 0 | 0 | 0 | For |
| Equitable | 172,663 | 0 | 0 | 0 | For |
| American Century | 155,788 | 0 | 0 | 0 | For |
| John Hancock | 134,953 | 0 | 0 | 0 | For |
| Northwestern Mutual | 99,267 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 87,220 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,047 | 0 | 0 | 0 | For |
| First Trust | 78,073 | 0 | 0 | 0 | For |
| Brighthouse | 71,470 | 0 | 0 | 0 | For |
| Invesco | 70,952 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 67,207 | 0 | 0 | 0 | For |
| Principal | 51,902 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,600 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 49,440 | 0 | 0 | 0 | For |
| Goldman Sachs | 45,216 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 45,088 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Rita I. Jain, M.D.
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Rita I. Jain, M.D.”): 54,826,340 for, 627,680 against, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2025.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 62 asset managers below reported 29,622,235 for, 6,895 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,368,618 | 0 | 0 | 0 | For |
| Vanguard | 8,068,532 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,113,701 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,485,625 | 0 | 0 | 0 | For |
| BlackRock | 1,550,187 | 0 | 0 | 0 | For |
| State Street | 1,502,105 | 354 | 0 | 0 | For |
| Hartford | 582,176 | 0 | 0 | 0 | For |
| Charles Schwab | 502,440 | 0 | 0 | 0 | For |
| TIAA | 369,232 | 0 | 0 | 0 | For |
| Prudential/PGIM | 341,172 | 0 | 0 | 0 | For |
| Equitable | 172,663 | 0 | 0 | 0 | For |
| American Century | 155,788 | 0 | 0 | 0 | For |
| John Hancock | 134,953 | 0 | 0 | 0 | For |
| Northwestern Mutual | 99,267 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 87,220 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,047 | 0 | 0 | 0 | For |
| First Trust | 78,073 | 0 | 0 | 0 | For |
| Brighthouse | 71,470 | 0 | 0 | 0 | For |
| Invesco | 70,952 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 67,207 | 0 | 0 | 0 | For |
| Principal | 51,902 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,600 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 49,440 | 0 | 0 | 0 | For |
| Goldman Sachs | 45,216 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 45,088 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.
Combines 5 wordings of this item as funds reported it.
97% Approved · of votes cast
Description as filed by funds: To approve an amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of shares reserved for issuance thereunder by 3,200,000 shares to 7,500,000 shares.
CELLDEX THERAPEUTICS INC.’s own tally for this item (“3. An amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of the shares reserved for issuance thereunder by 3,200,000 shares to 7,500,000 shares”): 53,889,397 for, 1,561,316 against — passed, per its Form 8-K filed June 14, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders approved an amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of the shares reserved for issuance thereunder by 3,200,000 shares to 7,500,000 shares.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,368,618 | 0 | 0 | 0 | For |
| Vanguard | 8,068,532 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,161,201 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,485,625 | 0 | 0 | 0 | For |
| BlackRock | 1,550,187 | 0 | 0 | 0 | For |
| State Street | 1,502,208 | 251 | 0 | 0 | For |
| Hartford | 582,176 | 0 | 0 | 0 | For |
| Charles Schwab | 502,440 | 0 | 0 | 0 | For |
| TIAA | 369,232 | 0 | 0 | 0 | For |
| Prudential/PGIM | 41,276 | 299,896 | 0 | 0 | Mixed |
| Equitable | 172,663 | 0 | 0 | 0 | For |
| American Century | 0 | 155,788 | 0 | 0 | Against |
| John Hancock | 134,953 | 0 | 0 | 0 | For |
| Northwestern Mutual | 99,267 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 87,220 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,047 | 0 | 0 | 0 | For |
| First Trust | 78,073 | 0 | 0 | 0 | For |
| Brighthouse | 71,470 | 0 | 0 | 0 | For |
| Invesco | 70,952 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 67,207 | 0 | 0 | 0 | For |
| Principal | 51,902 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,600 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 49,440 | 0 | 0 | 0 | For |
| Goldman Sachs | 45,216 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 45,088 | 0 | 0 | 0 | For |
Fund voting reports, all 61 managers: 29,186,448 for, 489,081 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Kynam Capital Management, LP | 0 | 0 | 0 | 2,509,189 | Withhold |
| Eversept Partners, LP | 648,737 | 0 | 0 | 0 | For |
| Keel Point, LLC | 1,101 | 0 | 0 | 0 | For |
| ALGERT GLOBAL LLC | 407 | 0 | 0 | 0 | For |
| LEAVELL INVESTMENT MANAGEMENT, INC. | 26 | 0 | 0 | 0 | For |
Institutional-manager reports, all 5 managers: 650,271 for, 2,509,189 withheld.
Combines 9 wordings of this item as funds reported it.
98% Approved · of votes cast
Description as filed by funds: To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in this Proxy Statement.
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Proposal 4: The stockholders voted to approve, on an advisory, non-binding basis, the compensation for the Company's named executive officers as disclosed in the Proxy Statement.”): 54,182,916 for, 945,004 against — passed, per its Form 8-K filed June 14, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders voted to approve, on an advisory, non-binding basis, the compensation for the Company's named executive officers as disclosed in the Proxy Statement.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,368,618 | 0 | 0 | 0 | For |
| Vanguard | 8,068,532 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,161,201 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,485,625 | 0 | 0 | 0 | For |
| BlackRock | 1,550,187 | 0 | 0 | 0 | For |
| State Street | 1,502,459 | 0 | 0 | 0 | For |
| Hartford | 582,176 | 0 | 0 | 0 | For |
| Charles Schwab | 502,440 | 0 | 0 | 0 | For |
| TIAA | 369,232 | 0 | 0 | 0 | For |
| Prudential/PGIM | 341,172 | 0 | 0 | 0 | For |
| Equitable | 172,663 | 0 | 0 | 0 | For |
| American Century | 155,788 | 0 | 0 | 0 | For |
| John Hancock | 134,953 | 0 | 0 | 0 | For |
| Northwestern Mutual | 99,267 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 87,220 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,047 | 0 | 0 | 0 | For |
| First Trust | 78,073 | 0 | 0 | 0 | For |
| Brighthouse | 71,470 | 0 | 0 | 0 | For |
| Invesco | 0 | 70,952 | 0 | 0 | Against |
| FINANCIAL INVESTORS TRUST | 67,207 | 0 | 0 | 0 | For |
| Principal | 51,902 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,600 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 49,440 | 0 | 0 | 0 | For |
| Goldman Sachs | 45,216 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 45,088 | 0 | 0 | 0 | For |
Fund voting reports, all 61 managers: 29,598,379 for, 77,150 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,243,816 | 0 | 0 | 0 | For |
| Wellington | 7,610,053 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,171,786 | 0 | 0 | 0 | For |
| Polar Capital Holdings Plc | 2,979,257 | 0 | 0 | 0 | For |
| State Street | 2,687,025 | 0 | 0 | 0 | For |
| Kynam Capital Management, LP | 0 | 0 | 0 | 2,509,189 | Withhold |
| BlackRock | 1,729,254 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,415,287 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 1,372,185 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 1,229,463 | 0 | 0 | 0 | For |
| COMMODORE CAPITAL LP | 866,468 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 810,954 | 0 | 0 | 0 | For |
| Woodline Partners LP | 728,244 | 0 | 0 | 0 | For |
| EcoR1 Capital, LLC | 650,000 | 0 | 0 | 0 | For |
| Eversept Partners, LP | 648,737 | 0 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 582,726 | 0 | 0 | 0 | For |
| Sofinnova Investments, Inc. | 526,357 | 0 | 0 | 0 | For |
| Charles Schwab | 502,440 | 0 | 0 | 0 | For |
| 5AM Venture Management, LLC | 497,270 | 0 | 0 | 0 | For |
| Nuveen | 371,953 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 371,219 | 0 | 0 | 0 | For |
| Logos Global Management LP | 336,072 | 0 | 0 | 0 | For |
| Candriam S.C.A. | 0 | 0 | 317,509 | 0 | Abstain |
| Northern Trust | 311,624 | 39 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 242,410 | 0 | 0 | 0 | For |
Institutional-manager reports, all 161 managers: 41,746,075 for, 600,159 against, 2,613,766 withheld, 318,364 abstained, 1,208 not voted. Showing the 25 largest; see all in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.7% Approved · of votes cast
Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2024.
CELLDEX THERAPEUTICS INC.’s own tally for this item (“2. The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024”): 57,840,728 for, 122,376 against — passed, per its Form 8-K filed June 14, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders approved the ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024.”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 62 asset managers below reported 29,676,379 for, 251 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,368,618 | 0 | 0 | 0 | For |
| Vanguard | 8,068,532 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,161,201 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,485,625 | 0 | 0 | 0 | For |
| BlackRock | 1,550,187 | 0 | 0 | 0 | For |
| State Street | 1,502,208 | 251 | 0 | 0 | For |
| Hartford | 582,176 | 0 | 0 | 0 | For |
| Charles Schwab | 502,440 | 0 | 0 | 0 | For |
| TIAA | 369,232 | 0 | 0 | 0 | For |
| Prudential/PGIM | 341,172 | 0 | 0 | 0 | For |
| Equitable | 172,663 | 0 | 0 | 0 | For |
| American Century | 155,788 | 0 | 0 | 0 | For |
| John Hancock | 134,953 | 0 | 0 | 0 | For |
| Northwestern Mutual | 99,267 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 87,220 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,047 | 0 | 0 | 0 | For |
| First Trust | 78,073 | 0 | 0 | 0 | For |
| Brighthouse | 71,470 | 0 | 0 | 0 | For |
| Invesco | 70,952 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 67,207 | 0 | 0 | 0 | For |
| Principal | 51,902 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,600 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 49,440 | 0 | 0 | 0 | For |
| Goldman Sachs | 45,216 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 45,088 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 65,910,548 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 14.21% |
| 2 | Vanguard | 12.24% |
| 3 | MUTUAL FUND SERIES TRUST | 4.80% |
| 4 | T. Rowe Price | 3.77% |
| 5 | BlackRock | 2.35% |
| 6 | State Street | 2.28% |
| 7 | Hartford | 0.88% |
| 8 | Charles Schwab | 0.76% |
| 9 | TIAA | 0.56% |
| 10 | Prudential/PGIM | 0.52% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 14.02% |
| 2 | Wellington | 11.55% |
| 3 | T. Rowe Price | 4.81% |
| 4 | Polar Capital Holdings Plc | 4.52% |
| 5 | State Street | 4.08% |
| 6 | Kynam Capital Management, LP | 3.81% |
| 7 | BlackRock | 2.62% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 2.15% |
| 9 | Rock Springs Capital Management LP | 2.08% |
| 10 | PICTET ASSET MANAGEMENT SA | 1.87% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Wellington Management | 11.60% | 13F |
| FMR LLC | 10.70% | DEF14A |
| BlackRock | 8.35% | 13F |
| FMR (Fidelity) | 7.53% | 13F |
| Vanguard Group | 6.00% | 13F |
| Eventide Asset Management, LLC. | 5.51% | DEF14A |
| RTW Investments, LP | 5.25% | DEF14A |
| T. Rowe Price | 4.68% | 13F |
| State Street | 4.52% | 13F |
| Geode Capital | 2.15% | 13F |
Percentages above are of 65,910,548 shares outstanding, as reported by CELLDEX THERAPEUTICS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CELLDEX THERAPEUTICS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 1, 2026; a live search always shows the current data.
At CELLDEX THERAPEUTICS INC.'s shareholder meeting held June 13, 2024, in the 2023-2024 proxy season, 202 asset managers reported how they voted on 12 ballot items in their SEC Form N-PX filings, covering 2,952 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as… — CELLDEX THERAPEUTICS INC.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: CELLDEX THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 14, 2024.
CELLDEX THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.